Medical News
Interim Analysis of a Phase 3 Trial of Povetacicept in IgA Nephropathy
New England Journal of Medicine - 23 Oct 2026 04:30
New England Journal of Medicine, Ahead of Print.
Ravulizumab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial
New England Journal of Medicine - 23 Oct 2026 04:30
New England Journal of Medicine, Ahead of Print.